Eren, A.E.; Aydin, A.A.; Aksaray, E.E.; Durak, A.; Unlu, A.; Islamoglu, M.E.; Ozturk, B.; Yildiz, M.
Pan-Immune-Inflammation Value as a Predictor of Long-Term Outcomes in Patients with Urothelial Carcinoma of the Bladder: A Pilot Study. Curr. Oncol. 2025, 32, 534.
https://doi.org/10.3390/curroncol32100534
AMA Style
Eren AE, Aydin AA, Aksaray EE, Durak A, Unlu A, Islamoglu ME, Ozturk B, Yildiz M.
Pan-Immune-Inflammation Value as a Predictor of Long-Term Outcomes in Patients with Urothelial Carcinoma of the Bladder: A Pilot Study. Current Oncology. 2025; 32(10):534.
https://doi.org/10.3390/curroncol32100534
Chicago/Turabian Style
Eren, Ali Erhan, Asim Armagan Aydin, Eren Erdi Aksaray, Arda Durak, Ahmet Unlu, Mahmut Ekrem Islamoglu, Banu Ozturk, and Mustafa Yildiz.
2025. "Pan-Immune-Inflammation Value as a Predictor of Long-Term Outcomes in Patients with Urothelial Carcinoma of the Bladder: A Pilot Study" Current Oncology 32, no. 10: 534.
https://doi.org/10.3390/curroncol32100534
APA Style
Eren, A. E., Aydin, A. A., Aksaray, E. E., Durak, A., Unlu, A., Islamoglu, M. E., Ozturk, B., & Yildiz, M.
(2025). Pan-Immune-Inflammation Value as a Predictor of Long-Term Outcomes in Patients with Urothelial Carcinoma of the Bladder: A Pilot Study. Current Oncology, 32(10), 534.
https://doi.org/10.3390/curroncol32100534
